Point72 Hong Kong’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-480
| Closed | -$88K | – | 2618 |
|
|
2021
Q2 | $88K | Sell |
480
-5,319
| -92% | -$913K | ﹤0.01% | 1346 |
|
|
2021
Q1 | $887K | Sell |
5,799
-1,118
| -16% | -$173K | 0.03% | 685 |
|
|
2020
Q4 | $1.08M | Buy |
+6,917
| New | +$889K | 0.05% | 451 |
|
|
2019
Q4 | – | Sell |
-1,171
| Closed | -$115K | – | 1554 |
|
|
2019
Q3 | $115K | Buy |
1,171
+1,030
| +730% | +$116K | 0.03% | 426 |
|
|
2019
Q2 | $18K | Buy |
+141
| New | +$18.2K | ﹤0.01% | 800 |
|
|
2018
Q3 | – | Sell |
-437
| Closed | -$54K | – | 1299 |
|
|
2018
Q2 | $54K | Sell |
437
-540
| -55% | -$63.1K | 0.02% | 416 |
|
|
2018
Q1 | $109K | Buy |
977
+947
| +3,157% | +$113K | 0.06% | 303 |
|
|
2017
Q4 | $4K | Buy |
+30
| New | +$3.65K | ﹤0.01% | 634 |
|
|
2017
Q2 | – | Sell |
-263
| Closed | -$32K | – | 1105 |
|
|
2017
Q1 | $32K | Buy |
+263
| New | +$33.9K | 0.04% | 325 |
|
|
2016
Q3 | – | Sell |
-96
| Closed | -$11K | – | 912 |
|
|
2016
Q2 | $11K | Buy |
+96
| New | +$13.6K | 0.01% | 419 |
|
|
2015
Q4 | – | Sell |
-128
| Closed | -$20K | – | 530 |
|
|
2015
Q3 | $20K | Buy |
+128
| New | +$23.3K | 0.03% | 102 |
|
|
2015
Q2 | – | Sell |
-3,828
| Closed | -$663K | – | 287 |
|
|
2015
Q1 | $663K | Buy |
+3,828
| New | +$693K | 0.59% | 16 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM